Clinical Trial Update: Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination chemotherapy regimen with pegfilgrastim in men with metastatic germ cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Teratoma
• Testicular Germ Cell Tumor

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Extragonadal Germ Cell Tumor, Teratoma | Phase 2 | Status: COMPLETED